Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of argireline capsule in China. Welcome to wholesale bulk high quality argireline capsule for sale here from our factory. Good service and reasonable price are available.
Argireline capsule is an artificially synthesized bioactive peptide with the chemical name acetyl hexapeptide-3. Its molecular formula is C₃₄H₆₀N₁₄O₁₂S and its molecular weight is approximately 889.00. Its structure is similar to that of natural neurotransmitters and can simulate the effect of botulinum bacteria, thus it is called "botulinum toxin". The core mechanism of action of Argireline is to inhibit the release of acetylcholine (a neurotransmitter) from the presynaptic membrane, reducing the transmission of muscle contraction signals, thereby relaxing facial expression muscles and alleviating dynamic lines (such as crow's feet and frown lines) formed by repeated muscle movements. In addition, Argireline can stimulate the synthesis of collagen and elastin in the dermis, enhance skin support, and improve static wrinkles and sagging problems.
|
|
|
Argireline COA
The Current Situation and Mysteries of Oral absorption
The challenge of oral absorption
As a polypeptide substance, Argireline faces many challenges in its oral absorption:
Gastrointestinal barrier: Drugs taken orally encounter digestive enzymes in the mouth, including amylase and lipase in saliva. After the drug reaches the gastric juice with a strong acidic environment and the presence of pepsin, etc., if the protein is not modified or some special excipients are added, the vast majority of the protein and polypeptides will denature and become inactive. After entering the intestinal tract, protein and polypeptide molecules will undergo more complex enzymatic degradation processes, such as CYP3A4 enzyme metabolism.
Physical barriers: Unactivated proteins and polypeptides need to overcome two barriers before they can be absorbed into the systemic circulation. The first physical barrier is the mucus layer of the gastrointestinal tract, and the second physical barrier is the closely connected epithelial cell layer. The two main mechanisms of drug absorption through the gastrointestinal mucosa are transcellular transport and the paracellular pathway. However, Argireline, as a polypeptide with strong hydrophilicity, is more inclined to pass through epithelial cells through the paracellular pathway, but this pathway is less efficient.
Research Status of Oral Absorption
At present, there are relatively few studies on the oral absorption of this product, and there is certain controversy.Some studies have shown that Argireline has poor stability in the gastrointestinal tract and is easily degraded by enzymes, resulting in a low oral bioavailability. However, there are also studies that have attempted to enhance its oral absorption efficiency through methods such as chemical modification and the addition of absorption promoters.
The mystery of oral absorption
Uncertainty of bioavailability
Due to the complex metabolic process of Argireline in the gastrointestinal tract, its oral bioavailability is difficult to predict accurately. The differences in factors such as gastrointestinal environment and enzyme activity among different individuals may lead to significant fluctuations in the absorption effect of Argireline.
Unclear absorption mechanism
At present, the specific absorption mechanism of Argireline in the gastrointestinal tract is not yet fully understood. Is it mainly absorbed through transcellular transport or paracellular pathways? Are there any specific transport proteins involved in its absorption process? These problems still remain to be further studied.
Interactions with other drugs
The interactions of Argireline with other drugs in the gastrointestinal tract are also a mystery. Will it affect the absorption and metabolism of other drugs? Will other drugs interfere with the absorption of Argireline? These problems are of great significance for the clinical application of this capsule.
Strategies for Enhancing Oral Absorption of Argireline
Chemical modification
Lipolization
By adding non-polar groups or removing polar groups, the overall polarity of a drug molecule is reduced to increase lipophilicity. However, lipidation reduces the water solubility of the original drug, resulting in a decrease in solubility. Moreover, a major drawback of lipidation is that it leads to a reduction in the receptor affinity of the drug.
Cationic
Compared with anionic drugs, cationic drugs have stronger permeability on the intestinal mucosa, which is due to the presence of negatively charged glycoproteins on the intestinal cell membrane.
Pegylation
Pegylation can enhance the water solubility of drugs, reduce their enzymatic degradation in the gastrointestinal tract, and may also improve drug absorption.
Prodrug design
Design Argireline in the form of a prodrug to stabilize it in the gastrointestinal tract. After reaching the site of action, it will be converted into the active form.
Add absorption promoters
Surfactants: The commonly used absorption promoters are surfactants, which usually increase the solubility and bioadhesion of drugs, thereby retaining more drug amounts at the absorption site and further enhancing the bioavailability of the drug.
Fatty acids: Fatty acids can alter the structural integrity of epithelial cells and facilitate the passage of drugs through the gastrointestinal mucosa.
Glycerides: Glycerides have a similar mechanism of action and can enhance the absorption efficiency of drugs.
Bile salts: Bile salts can enhance the fluidity of cell membranes and promote the transcellular transport of drugs.
Chitosan: Chitosan is a natural polysaccharide with excellent biocompatibility and bioadhesion. It can increase the retention time of drugs in the gastrointestinal tract and promote absorption.
Cholesterol: Cholesterol can be embedded in cell membranes, altering their fluidity and facilitating the absorption of drugs.
Improvement of formulation technology
Preparing Argireline into nanomedicines such as nanoparticles and liposomes can enhance the stability and solubility of the drug, while increasing the contact area between the drug and the cell membrane and promoting absorption.
Microsphere preparations can control the release rate of drugs, reduce the local excessive concentration of drugs in the gastrointestinal tract, and lower the risk of enzymatic degradation.
Due to the very low content of proteolytic enzymes in the large intestine, transporting drugs to the large intestine for release can solve the enzyme barrier problem. Moreover, it has been found that peptide drugs have good absorption at the end of the small intestine. The colon-targeted drug delivery system is expected to solve the physiological barrier problem of peptide drugs. Colon-targeted preparations can be designed by utilizing methods such as time-delay effects, differences in gastrointestinal pH, and specific cell lines of the colon.
Anti-wrinkle effect
Improvement of dynamic lines
Argireline relaxes the facial expression muscles by inhibiting the release of neurotransmitters and reducing the transmission of muscle contraction signals, thereby alleviating dynamic lines formed by repeated muscle movements. Clinical trials have shown that products containing 2% to 5% Argireline can improve wrinkles by 30% to 50%.
Improvement of static lines and sagging
Argireline can also stimulate the synthesis of collagen and elastin in the dermis, enhance skin support, and improve static lines and sagging issues. Long-term use of the Argireline Capsule may help enhance the firmness and elasticity of the skin.
Safety and tolerance
Low irritation
Argireline has good biocompatibility and is suitable for sensitive skin as well. However, when administered orally, its safety still needs to be paid attention to, especially in cases of high doses or long-term use.
Side effect monitoring
At present, there are relatively few studies on its side effects.However, oral polypeptide drugs may cause gastrointestinal discomfort, allergic reactions, etc. During the usage process, it is necessary to closely monitor the patient's reaction and adjust the medication plan in a timely manner.
Effects on other physiological systems
Potential effects on the nervous system
As Argireline acts on the process of neurotransmitter release, it is unclear whether long-term oral administration will have other potential effects on the nervous system. The safety of its long-term use needs to be further studied.
The impact on the endocrine system
Whether Argireline will affect the function of the endocrine system also needs further exploration. For example, will it affect the secretion and metabolism of hormones?
Clinical application prospects and challenges
Clinical application prospects
The demand of the anti-aging market
With the continuous increase in people's attention to beauty and anti-aging, the product, as a potential oral anti-wrinkle product, has broad market prospects.
Combined application with other treatment methods
It can be combined with other anti-aging treatment methods (such as topical skin care products, injection cosmetology, etc.) to exert a synergistic effect and improve the therapeutic effect.
Challenges faced
The challenges of oral absorption
As mentioned earlier, the oral absorption of Argireline faces numerous challenges and requires further research and development of effective methods to enhance absorption efficiency.
Deficiencies in clinical research
Currently, there are relatively few clinical studies on Argireline Capsule, and there is a lack of large-scale, multi-center clinical trial data to support its efficacy and safety.
Regulatory and regulatory requirements
The research and development and marketing of oral polypeptide drugs must meet strict regulatory and regulatory requirements, including evaluations of drug safety, efficacy, and quality controllability.
Fundamental Molecular R&D (1993-2002)
The research and development of Acetyl Hexapeptide-8, the core molecule of Argireline, was initiated in 1993 by a multidisciplinary team from Lipotec, a Spanish biotechnology company (later acquired by Lubrizol), in collaboration with the University of California, San Diego. At that time, although botulinum toxin delivered remarkable results in the field of aesthetic anti-aging, its high toxicity and the limitations of invasive injection prompted the team to seek a safe alternative. The research focused on the SNARE complex in neuromuscular transmission and identified the SNAP-25 protein as a key component of this complex.
Its N-terminal fragment could interfere with the assembly of the complex and inhibit the release of acetylcholine, thereby reducing muscle contraction. Through rational molecular design, the team mimicked the amino acid sequence of residues 12-17 of the SNAP-25 protein and synthesized the hexapeptide molecule Ac-EEMQRR-NH₂, naming it Argireline (Acetyl Hexapeptide-8). In 2002, relevant research was published in the Journal of Cosmetic Dermatology, confirming that this polypeptide could reduce wrinkle depth by 30% with no significant toxicity, laying a solid foundation for the subsequent development of dosage forms.
Popularization of Topical Raw Materials and Exploration of Oral Dosage Forms (2002-2010)
After 2002, Argireline rapidly gained popularity as a topical anti-aging raw material and became the core ingredient of "topical botulinum toxin alternatives". However, topical preparations suffered from low skin penetration efficiency and limited action on the epidermis, which led the research team to explore oral dosage forms to improve bioavailability and potential systemic effects.
Two key technical challenges were addressed in this phase: first, to protect the peptide chain structure from degradation by gastrointestinal enzymes, the team adopted microencapsulation technology; second, to enhance intestinal absorption, carrier materials such as liposomes and chitosan were used to improve the transmembrane transport efficiency of the molecule, providing crucial technical support for the development of capsule dosage forms.
Formulation of Oral Capsules and Clinical Validation (2010-2018)
After 2010, with the gradual maturation of oral preparation technologies, Argireline Capsule entered the phase of formulation R&D. The R&D team optimized the capsule formulation by adopting an enteric-coated shell to prevent drug inactivation in gastric acid and ensure precise release in the intestines; meanwhile, suitable fillers and stabilizers were screened to guarantee the biological activity and storage stability of the polypeptide.
From 2015 to 2018, a number of clinical studies were conducted, and the results showed that oral Argireline Capsule could act on the muscles of the face and other parts through systemic circulation, inhibit excessive contraction, reduce dynamic wrinkles, and exhibit good safety with no side effects such as muscle paralysis, verifying the feasibility and effectiveness of the oral dosage form.
Market Promotion and Application Expansion (2018-Present)
After 2018, the product was commercialized, initially positioned as an oral anti-aging product for populations who refuse injectable treatments and pursue convenient anti-aging solutions. With in-depth research, its applications have expanded to the adjuvant improvement of local muscle tension and other fields.
At the same time, enterprises have continuously optimized production processes-such as adopting solid-phase synthesis to improve polypeptide purity and upgrading encapsulation technologies to enhance bioavailability-driving the product toward high efficiency, safety and stability. It has become a representative product in the field of oral anti-aging polypeptides, promoting the penetration of anti-aging polypeptides from the professional aesthetic medicine field into daily health management.
Conclusion
The oral absorption of it is a mysterious field, and its absorption efficiency and mechanism are not yet fully understood. However, through methods such as chemical modification, addition of absorption promoters, and improvement of formulation technology, it is expected to enhance the oral absorption efficiency of Argireline, thereby exerting its systemic effects such as anti-wrinkle. In future studies, it is necessary to further explore the oral absorption mechanism of Argireline in depth, carry out large-scale clinical studies, evaluate its efficacy and safety, and provide a scientific basis for the clinical application of it.At the same time, it is also necessary to pay attention to its possible impact on other physiological systems to ensure the safe use of the drug. With the continuous advancement of technology and the in-depth research, it is expected to become a safe and effective oral anti-wrinkle product, bringing new options to the anti-aging market.
FAQ
What is Argireline used for?
+
-
Argireline is the trade name for acetyl hexapeptide-8, a synthetic peptide composed of a chain of amino acids. When applied to the skin, acetyl hexapeptide-8 has been shown to relax the appearance of expression lines and contribute to a smoother-looking complexion.
Is it safe to use Argireline every day?
+
-
According to one study, Argireline has been found to be safer than Botox and can reduce wrinkles by up to 48% within four weeks when applied twice daily.
Hot Tags: argireline capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale